Portal
Order

MI Cancer Seek® is now available for clinical ordering. Learn more.

Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

Publications

Back

Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

– Caris Life Sciences

Poster

Background

A great need exists for new therapeutic approaches for patients with pancreatic cancer

Download Publication

Discover
More

  • Regorafenib response prediction in metastatic colorectal cancer by a novel genomic and transcriptomic model

    – Caris Life Sciences

    Poster

    Introduction: Regorafenib is a third-line option in metastatic CRC, often overshadowed by its limited efficacy and high toxicity. Yet, rare cases of deep and even… […]

  • Effect of elevated expression of LILRB4 and TSC22D3 on survival in lung cancer

    – Caris Life Sciences

    Poster

    Background: LILRB4 and TSC22D3 in Inflammation HER2/neu mutations or amplifications can activate STAT3 to promote inflammation and suppressing adaptive immune responses. Elevated systemic inflammation-immune index… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)